Multiple myeloma: detecting the effects of new treatments

The Lancet

Volumn 371, Issue 9625, 2008, Pages 1642-1644

  Djulbegovic, Benjamin ^a   Kumar, Ambuj ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BORTEZOMIB; DEXAMETHASONE; DOXORUBICIN; LENALIDOMIDE; MELPHALAN; PREDNISONE; STEROID; THALIDOMIDE; VINCRISTINE;

ARTICLE; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; MONOTHERAPY; MULTIPLE MYELOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE;

EID: 43449130689     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60704-7     Document Type: Note

References (18)